Thursday, July 30, 2015

Catching up with Christine Pierre and clinical trials

Friday, July 10, 2015, 1:41 PM
Clinical trials have been a consistent theme in this blog and I continue to advocate trial participation for melanoma and other cancers. Forbes recently wrote an article on my involvement with the work done by Christine Pierre, the president of the Society for Clinical Research Sites (SCRS). Wait,... Read more

From Patient #1 to supporting son

Tuesday, June 30, 2015, 12:40 PM
Well, this is different. I live with cancer, I write about it, I advocate for advancement in treatment, I communicate with cancer patients, and I attend oncology conferences and melanoma fundraisers to support those endeavors. What I have yet to do is care for a cancer patient. Until today. My mom... Read more

Tara Miller: Making the best of it

Thursday, June 25, 2015, 10:30 AM
I have done a few stories on fellow cancer patients, and one in particular continues to resonate with the mission of the Patient #1 blog. Tara Miller grew up at the Jersey Shore, not far from where my grandparents lived, and was set to be the next big legal expert in Atlantic County until melanoma... Read more

How to understand clinical trial results

Wednesday, June 10, 2015, 10:57 AM
After ASCO 2015 finished, I sat down to write about it… and hours later, I was still procrastinating. That’s when an email came through that prompted an 800-word comments-section response on an alternative cancer blog. The post was “debunking” the media take on the “big... Read more

PD-1 makes big splash at 2015 ASCO

Friday, June 5, 2015, 12:21 PM
The American Society of Clinical Oncology recently held the world’s biggest annual cancer conference, ASCO 2015. Once again, immunotherapy played a prominent role. While I didn’t travel to Chicago for the circus of science, I did still had access to the meeting abstracts (not that it did... Read more

How one cancer survivor sought out the best treatment

Monday, May 18, 2015, 12:19 PM
Seeking out the best treatment option is an issue I’ve been advocating for two years. I got an email from a fellow melanoma patient who happened on the blog, thanked me for the voice I provide, and asked how she could help raise awareness. She was thinking “how can I volunteer?”... Read more

The importance of applying sunscreen

Friday, May 15, 2015, 3:22 PM
Believe it or not, Memorial Day Weekend is 168 hours away. It’s the start of summertime at the Shore – and prime sunburn season. Rather than bore you with my annual lectures on how to wear sunscreen and why, I’ll use recent news to highlight its importance, especially with the kids... Read more

Reflecting on some ups and downs

Friday, May 8, 2015, 9:16 AM
My New Year’s vow of more frequent updates has not exactly panned out how I thought it would. I have a ton of information and struggle sometimes to find the right context to present it. So let’s do a quick recap of some of the last few weeks’ ups and downs. Oh yea, my infusion and... Read more

A patient looks at 40

Friday, May 1, 2015, 11:50 AM
Yes I am a pirate, two hundred years too late. The cannons don't thunder, there’s nothing to plunder, I’m an over-40 victim of fate…” - Jimmy Buffett, ‘A Pirate Looks At 40’ Two birthdays ago, I received my second dose of an experimental melanoma treatment known... Read more

At AACR, patients' odds are shifting

Monday, April 20, 2015, 1:33 PM
If you see a bunch of very smart people wandering around Center City this week, it’s the 19,000 or so attendees at the American Association for Cancer Research (AACR) Annual Meeting. These conferences happen every few months and are a chance for researchers to present ongoing studies to peers... Read more
About this blog
T.J. Sharpe is sharing his fight against Stage 4 Melanoma. A South Jersey native and Bishop Eustace graduate, he currently lives in Fort Lauderdale, FL with his wife Jennifer and children Josie and Tommy. He was Patient #1 in a clinical trial at Moffitt Cancer Center in Tampa as the first person worldwide to use this sequence of treatments to fight melanoma, and is currently in a second clinical trial at Holy Cross Hospital in Fort Lauderdale receiving Merck’s anti-PD-1 drug Lambrolizumab

The Patient #1 blog will update the progress of T.J.'s fight against cancer, and also touch on many cancer-related topics.

Follow T.J. on Twitter and Facebook. Reach T.J. at

T.J. Sharpe
Latest Health Videos
Also on
letter icon Newsletter